Consumer Health

The self-medication trend is growing in South Korea, supporting further sales growth for analgesics, and cough, cold and allergy (hay fever) remedies, especially since the prevalence of the “tripledemic” in the country, consisting of COVID-19,…

The second half of 2022 and the first half of 2023 saw declining demand for many areas of OTC healthcare. This was linked to high inflation and the related decline in disposable incomes. Consumers have turned away from buying non-essential products…

Consumer health shows variable recovery in 2023, with an ongoing return to the normalisation of sales patterns following the atypical period of the pandemic. Challenges, however, continue, such as the departure of President Castillo's government, in…

Pakistan’s economy continues to struggle and the government secured a further USD3 billion bailout with the IMF in July 2023, avoiding an impending default. Inflation continues to be very high and is being driven by several factors, including…

While consumer health in Hungary is set to post robust growth in total current value sales in 2023, this is primarily due to inflationary pressures fuelled by the global recovery from the pandemic, the fallout of Russia’s invasion of Ukraine and the…

In 2023, the consumer health market in Bulgaria is set to see steady current value growth, with sales set to continue to fall at constant 2023 prices, though at a slower rate than in the previous year in both cases. Consumer preferences are shifting…

Consumer health in Azerbaijan is seeing something of a resurgence in 2023. New entrants are livening up the marketplace, and fresh medications are making their mark. The once-stringent Tariff Regulatory Authority has taken a step back, loosening the…

Despite the overall waning impact of the pandemic in South Korea, simultaneous new outbreaks of COVID-19, influenza, and the common cold (referred to as a “tripledemic” in the country) are leading to a sharp increase in the number of consumers…

In 2023, analgesics is set to see strong growth supported by rising prices in the context of generally high rates of inflation. After strong growth in 2020 due to stockpiling and decline in 2021, the category returned to growth in 2022 and has…

Analgesics benefitted from the era of COVID-19, as consumers sought out pain relief such as acetaminophen and ibuprofen, both of which saw extensive coverage in the media as low-cost products that could treat symptoms of the virus quickly and…